Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 220S220 trades$52.89M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
MSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
FFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
MGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Mills Jason FahrDirector |  EXFYExpensify, Inc.Grant or award | A | — 1.16M sh | Jun 25, 2026 |
| 5 | Cordella Richard James JRDirector |  MVBFMVB FINANCIAL CORPOption exercise | M | — 3,701 sh | Jun 25, 2026 traded Jun 23, 2026 |
| 5 | Hull Thomas David IiiDirector, President & CEO |  KEQUKEWAUNEE SCIENTIFIC CORP /DE/Grant or award | A | — 15.2K sh | Jun 25, 2026 traded Jun 24, 2026 |
| 5 | Coetzee MichaelVP and GM Fuel Syst. Americas |  PHINPHINIA INC.Grant or award | A | — 33 sh | Jun 25, 2026 traded Jun 23, 2026 |
| 5 | Schaffer RyanDirector, Chief Financial Officer | EXFYExpensify, Inc. Grant or award | A | — 1.16M sh | Jun 25, 2026 traded Jun 23, 2026 |
| 5 | Mendelsohn AaronDirector |  VANIVivani Medical, Inc.Grant or award | A | $45K 36.5K sh | Jun 25, 2026 traded Jun 24, 2026 |
| 4 | Schlosser MarioDirector |  OSCROscar Health, Inc.Derivative conversion · 10b5-1 plan | C | — 880.0K sh | Jun 25, 2026 traded Jun 23, 2026 |
| 4 | Schlosser MarioDirector | OSCROscar Health, Inc. Derivative conversion · 10b5-1 plan | C | — 880.0K sh | Jun 25, 2026 traded Jun 23, 2026 |
| 3 | Bizily ScottChief Legal Officer |  FDMT4D Molecular Therapeutics, Inc.Option exercise · 10b5-1 plan | M | — 9,810 sh | Jun 25, 2026 traded Jun 23, 2026 |
| 2 | Barrett David MichaelDirector, Chief Executive Officer | EXFYExpensify, Inc. Grant or award | A | — 2.09M sh | Jun 25, 2026 traded Jun 23, 2026 |
| 1 | Schlosser MarioDirector | OSCROscar Health, Inc. Open-market sale · 10b5-1 plan | SELL | $54K 1,799 sh | Jun 25, 2026 traded Jun 23, 2026 |
| 0 | Alclear Investments, LLCDirector, 10% Owner, See Remarks |  YOUClear Secure, Inc.Disposition to issuer · 10b5-1 plan | D | — 16.0K sh | Jun 25, 2026 traded Jun 24, 2026 |
| 0 | Doyle MittieChief Medical Officer |  AVTXAvalo Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $26K 1,450 sh | Jun 25, 2026 traded Jun 23, 2026 |
| 0 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | YOUClear Secure, Inc. Grant or award · 10b5-1 plan | A | — 16.0K sh | Jun 25, 2026 traded Jun 24, 2026 |
| 0 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | YOUClear Secure, Inc. Disposition to issuer · 10b5-1 plan | D | — 196.6K sh | Jun 25, 2026 traded Jun 25, 2026 |
| 0 | Schmidt James FDirector, CFO, Treasurer, Secretary |  VICRVICOR CORPOption exercise · 10b5-1 plan | M | — 331 sh | Jun 25, 2026 traded Jun 24, 2026 |
| 0 | Ring ChristineChief Legal Officer |  NRIXNurix Therapeutics, Inc.Option exercise · 10b5-1 plan | M | — 13.3K sh | Jun 25, 2026 traded Jun 25, 2026 |
| 0 | Schlosser MarioDirector | OSCROscar Health, Inc. Derivative conversion · 10b5-1 plan | C | — 50.0K sh | Jun 25, 2026 traded Jun 23, 2026 |
| 0 |  Silbermann BenjaminDirector, 10% Owner |  PINSPINTEREST, INC.Derivative conversion · 10b5-1 plan | C | — 0 sh | Jun 25, 2026 traded Jun 23, 2026 |
| 0 | Silbermann BenjaminDirector, 10% Owner | PINSPINTEREST, INC. Derivative conversion · 10b5-1 plan | C | — 46.9K sh | Jun 25, 2026 traded Jun 23, 2026 |
| 0 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 107.7K sh | Jun 25, 2026 traded Jun 23, 2026 |
| 0 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | YOUClear Secure, Inc. Disposition to issuer · 10b5-1 plan | D | — 196.6K sh | Jun 25, 2026 traded Jun 25, 2026 |
| 0 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | YOUClear Secure, Inc. Grant or award · 10b5-1 plan | A | — 196.6K sh | Jun 25, 2026 traded Jun 25, 2026 |
| 0 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | YOUClear Secure, Inc. Disposition to issuer · 10b5-1 plan | D | — 196.6K sh | Jun 25, 2026 traded Jun 25, 2026 |
| 0 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 107.7K sh | Jun 25, 2026 traded Jun 23, 2026 |
| 0 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | YOUClear Secure, Inc. Grant or award · 10b5-1 plan | A | — 16.0K sh | Jun 25, 2026 traded Jun 24, 2026 |
| 0 | Schlosser MarioDirector | OSCROscar Health, Inc. Derivative conversion · 10b5-1 plan | C | — 47.5K sh | Jun 25, 2026 traded Jun 23, 2026 |
| 0 | Remer Eric RichardDirector, Chief Executive Officer |  EVCMEverCommerce Inc.Open-market sale · 10b5-1 plan | SELL | $9,929 1,100 sh | Jun 25, 2026 traded Jun 23, 2026 |
| 0 | Schmidt James FDirector, CFO, Treasurer, Secretary | VICRVICOR CORP Option exercise · 10b5-1 plan | M | $20K 331 sh | Jun 25, 2026 traded Jun 24, 2026 |
| 0 | Silbermann BenjaminDirector, 10% Owner | PINSPINTEREST, INC. Derivative conversion · 10b5-1 plan | C | — 0 sh | Jun 25, 2026 traded Jun 24, 2026 |
| 0 | Schlosser MarioDirector | OSCROscar Health, Inc. Option exercise · 10b5-1 plan | M | — 660.0K sh | Jun 25, 2026 traded Jun 23, 2026 |
| 0 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 15.6K sh | Jun 25, 2026 traded Jun 25, 2026 |
| 0 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | YOUClear Secure, Inc. Disposition to issuer · 10b5-1 plan | D | — 16.0K sh | Jun 25, 2026 traded Jun 24, 2026 |
| 0 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | YOUClear Secure, Inc. Disposition to issuer · 10b5-1 plan | D | — 16.0K sh | Jun 25, 2026 traded Jun 24, 2026 |
| 0 | Schlosser MarioDirector | OSCROscar Health, Inc. Derivative conversion · 10b5-1 plan | C | — 50.0K sh | Jun 25, 2026 traded Jun 23, 2026 |
| 0 | Silbermann BenjaminDirector, 10% Owner | PINSPINTEREST, INC. Derivative conversion · 10b5-1 plan | C | — 46.9K sh | Jun 25, 2026 traded Jun 24, 2026 |
| 0 | Schlosser MarioDirector | OSCROscar Health, Inc. Derivative conversion · 10b5-1 plan | C | — 47.5K sh | Jun 25, 2026 traded Jun 23, 2026 |
| 0 | Doyle MittieChief Medical Officer | AVTXAvalo Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 1,450 sh | Jun 25, 2026 traded Jun 23, 2026 |
| 0 | Schlosser MarioDirector | OSCROscar Health, Inc. Derivative conversion · 10b5-1 plan | C | — 50.0K sh | Jun 25, 2026 traded Jun 23, 2026 |
| 0 | Doyle MittieChief Medical Officer | AVTXAvalo Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $12K 1,450 sh | Jun 25, 2026 traded Jun 23, 2026 |